Kyntra Bio, Inc. (KYNB)
6.27
+0.31
(+5.20%)
USD |
NASDAQ |
Oct 09, 14:36
Kyntra Bio Market Cap : 25.39M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 24.13M |
| October 07, 2026 | 24.82M |
| October 06, 2026 | 24.13M |
| October 05, 2026 | 24.66M |
| October 02, 2026 | 25.55M |
| October 01, 2026 | 26.32M |
| September 30, 2026 | 26.93M |
| September 29, 2026 | 27.49M |
| September 28, 2026 | 27.94M |
| September 25, 2026 | 28.10M |
| September 24, 2026 | 28.34M |
| September 23, 2026 | 29.36M |
| September 22, 2026 | 29.48M |
| September 21, 2026 | 29.15M |
| September 18, 2026 | 28.65M |
| September 17, 2026 | 28.75M |
| September 16, 2026 | 30.81M |
| September 15, 2026 | 31.46M |
| September 14, 2026 | 32.51M |
| September 11, 2026 | 32.27M |
| September 10, 2026 | 32.29M |
| September 09, 2026 | 32.55M |
| September 08, 2026 | 33.28M |
| September 04, 2026 | 34.62M |
| September 03, 2026 | 34.38M |
| Date | Value |
|---|---|
| September 02, 2026 | 34.54M |
| September 01, 2026 | 32.19M |
| August 31, 2026 | 31.50M |
| August 28, 2026 | 32.47M |
| August 27, 2026 | 32.39M |
| August 26, 2026 | 32.82M |
| August 25, 2026 | 32.80M |
| August 24, 2026 | 32.31M |
| August 21, 2026 | 30.45M |
| August 20, 2026 | 29.64M |
| August 19, 2026 | 28.95M |
| August 18, 2026 | 28.38M |
| August 17, 2026 | 27.57M |
| August 14, 2026 | 28.55M |
| August 13, 2026 | 28.51M |
| August 12, 2026 | 28.75M |
| August 11, 2026 | 28.63M |
| August 10, 2026 | 28.22M |
| August 07, 2026 | 29.43M |
| August 06, 2026 | 28.26M |
| August 05, 2026 | 28.30M |
| August 04, 2026 | 28.01M |
| August 03, 2026 | 27.37M |
| July 31, 2026 | 27.24M |
| July 30, 2026 | 27.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vericel Corp. | 2.072B |
| Nektar Therapeutics | 1.403B |
| Capricor Therapeutics, Inc. | 454.99M |
| ARS Pharmaceuticals, Inc. | 425.10M |
| ACADIA Pharmaceuticals, Inc. | 3.424B |
Market Cap Related Metrics
| PE Ratio | 0.1941 |
| PS Ratio | 5.495 |
| Price | 6.27 |
| Earnings Yield | 515.2% |
| Normalized PE Ratio | 0.1874 |